ArticleBritish journal of cancer2015

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells.

F Caiazza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.